Director

Thomas J. Gunderson

Director; Chairperson of the Compensation Committee·TransMedics Group, Inc.

About

Thomas J. Gunderson has served on the TransMedics Board since August 2016.

He was managing director and senior research analyst at Piper Jaffray, focused on medical technology companies, from 1992 to 2016, and was a member of the American Heart Association Science and Technology Accelerator Committee from 2015 to 2017.

He currently serves as Chair of the Board of Directors of the Minneapolis Heart Institute Foundation (2015-2020 and 2024-present), as Executive in Residence at the University of Minnesota's Medical Industry Leadership Institute since 2016, and as a director of Merit Medical Systems, Inc. since 2017.

Since August 2016
Age 75
Tenure 10 yrs

Also at TransMedics Group, Inc.

WM Waleed H. Hassanein, M.D. Founder, President and Chief Executive Officer; Director JT James R. Tobin Director; Chairperson of the Board EB Edward M. Basile Director; Chairperson of the Nominating and Corporate Governance Committee EJ Edwin M. Kania, Jr. Director SL Stephanie Lovell Director MR Merilee Raines Director; Chairperson of the Audit Committee

Roles

Organization Role Dates Details
TransMedics Group, Inc. Director; Chairperson of the Compensation Committee August 2016–present Current role
Piper Jaffray Managing director and senior research analyst 1992-2016 Focus on medical technology companies.
American Heart Association Science and Technology Accelerator Committee Member 2015-2017

External roles

Organization Role Dates
Merit Medical Systems, Inc. Director 2017-present
Minneapolis Heart Institute Foundation Chair of the Board of Directors 2015-2020; 2024-present
University of Minnesota Medical Industry Leadership Institute Executive in Residence 2016-present

Related

Company TransMedics Group, Inc. Company hub Person Waleed H. Hassanein, M.D. Founder, President and Chief Executive Officer; Director Person James R. Tobin Director; Chairperson of the Board Person Edward M. Basile Director; Chairperson of the Nominating and Corporate Governance Committee Person Edwin M. Kania, Jr. Director Person Stephanie Lovell Director Person Merilee Raines Director; Chairperson of the Audit Committee Person David Weill, M.D. Director Person Gerardo Hernandez Chief Financial Officer and Treasurer Person Giovanni Cecere Chief Commercial Officer Person Nicholas Corcoran Senior Vice President of Supply Chain and Operations Person Matthew Forsyth Senior Vice President, General Counsel and Corporate Secretary Person Tamer Khayal, M.D. Senior Vice President of International (former Chief Commercial Officer)
Source: TransMedics Group, Inc. proxy statement (SEC Schedule 14A)

Where the filing does not disclose a value, this page states "Not disclosed" rather than estimating. Smaller filers are exempt from disclosing metric targets and achievement, and larger filers may omit forward targets for competitive reasons.

See how VectorShift works for your firm

Request Demo